Seraprevir

赛拉瑞韦钾

Report date: 2022/11/25 14:19:51
NME

Base Information

Drug NameSeraprevir
Drug Alias NameSeraprevir PotassiumGP-205
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus serine protease, NS3/NS4A inhibitors
TargetsHepatitis C virus serine protease, NS3/NS4A
Therapy Area/IndicationsHepatitis C, ChronicHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesGinkgo Tree Pharmaceutical (Suzhou) Co LtdSecond Military Medical University Of Chinese People'S Liberation ArmyFirst Hospital Of Jilin University +[4] 
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesYiling Pharmaceutical LtdGinkgo Tree Pharmaceutical (Suzhou) Co Ltd
Inactive CompaniesGinkgopharma Co Ltd
Active IndicationsHepatitis C, Chronic
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A